Marta Giménez-Alejandre

Author

Institut d'Investigació Biomédica de Bellvitge ORCID

Also Known As

M Gimenez-Alejandre, M. Giménez-Alejandre, Marta Gimenez-Alejandre, Marta Giménez-Alejandre

Publications

665

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigació Biomédica de Bellvitge Institut Català d'Oncologia Centro de Investigación Biomédica en Red de Cáncer Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona

About

Marta Giménez-Alejandre is an author at Institut d'Investigació Biomédica de Bellvitge specializing in medicine, virology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	122
2	Biomolecular Engineering	2	2	63
3	Cell Biology	2	2	77
4	Engineering	1	1	52
5	Natural Sciences	1	1	11

Marta Giménez-Alejandre

Publications

648

Citations

H-Index

Page 1

	Year	Citations
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression Alba Rodríguez-García, Marta Giménez-Alejandre, Juan J. Rojas, Clinical Cancer Research	2014	113
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01 Guillem Pascual‐Pasto, Miriam Bazán‐Peregrino, Nagore G. Olaciregui, Science Translational Medicine	2019	109
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects Miriam Bazán‐Peregrino, Rocio García‐Carbonero, Berta Laquente, Journal for ImmunoTherapy of Cancer	2021	82
Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting Neus Bayó-Puxan, Marta Giménez-Alejandre, Sergio Lavilla-Alonso, Human Gene Therapy EngineeringTumor-targeting Transduction PropertiesPathologyAdenovirus Type 5Viral Structural Protein	2009	52
pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation Olga Boix, Marion Martinez, Santiago Vidal, Nature Communications	2022	47
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition Irene Andreu-Saumell, Alba Rodríguez-García, Vanessa Mühlgrabner, Nature Communications	2024	47
Combined Fiber Modifications Both to Target α <sub>v</sub> β <sub>6</sub> and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles <i>In Vivo</i> but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5 Lynda Coughlan, Sabari Vallath, Alena Gros, Human Gene Therapy	2012	41
TUNAR lncRNA Encodes a Microprotein that Regulates Neural Differentiation and Neurite Formation by Modulating Calcium Dynamics Elena Senís, Miriam Esgleas, Sònia Najas, Frontiers in Cell and Developmental Biology	2021	37
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD Juan J. Rojas, Marta Giménez-Alejandre, Raúl Gil-Hoyos, Gene Therapy Systemic Antitumor TherapyOncolytic AdenovirusesMedicineImmunologyBiological Therapy	2011	34
Coagulation Factors Determine Tumor Transduction <i>In Vivo</i> Marta Giménez-Alejandre, Manel Cascalló, Neus Bayó-Puxan, Human Gene Therapy	2008	27

Page 1